中威電子(300270.SZ)擬定增募資不超5.31億元 由新鄉市新投產業併購投資基金壹號認購
格隆匯 8 月 30日丨中威電子(300270.SZ)披露2020年度向特定對象發行A股股票預案,擬向特定對象發行股票的數量為不超過9084.18萬股(含本數),此次發行僅有1名特定對象新鄉市新投產業併購投資基金壹號合夥企業(有限合夥)參與認購,並已與公司簽署附條件生效的《股份認購協議》,全部以現金認購。
發行價為5.84元/股,不低於定價基準日前二十個交易日公司股票交易均價的百分之八十,符合《創業板上市公司證券發行註冊管理辦法(試行)》的規定。
募集資金總額預計不超過約5.31億元(含本數),扣除發行費用後,募集資金淨額將用於補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.